• NAD+ and Caspase-Linked Stress Adaptation

  2026-08-28

  A translational framework for using NAD+ to interrogate metabolic state, caspase-dependent stress adaptation, autophagy, and DNA damage responses without overstating what current evidence proves.

• Luminescent ATP Detection Assay Kit for ICD Research

  2026-08-27

  Use a sensitive firefly luciferase ATP assay to connect treatment-induced energy changes with immunogenic cell death in colorectal cancer models. Gentle lysis, broad linearity, and compatibility with protein workflows make this kit useful for paired cell, tissue, and conditioned-medium experiments.

• Superoxide Dismutase Activity Assay Kit

  2026-08-27

  The Superoxide Dismutase Activity Assay Kit (SKU K2035) provides a colorimetric method for quantifying SOD activity in biological fluids through inhibition of WST-1 formazan formation. It is suitable for research workflows involving oxidative stress and antioxidative enzyme activity, but it should not be used for diagnosis, treatment decisions, or unvalidated sample types.

• Sitagliptin Phosphate Monohydrate in Gut–Brain Assays

  2026-08-26

  Sitagliptin phosphate monohydrate is a selective DPP-4 inhibitor for dissecting incretin biology and glucose regulation. This article develops an assay strategy that separates peptide stabilization from intestinal stretch signaling, enabling more informative metabolic disease research.

• PCN, GR, and Hippocampal CYP in Phenytoin Toxicity

  2026-08-26

  The 2025 reference study identifies an organ-specific action of pregnenolone 16α-carbonitrile: it induces CYP3A11 and CYP2B10 in mouse liver but suppresses these enzymes in the hippocampus. The hippocampal response reduced phenytoin-associated testosterone metabolism and neuronal injury through glucocorticoid receptor signaling rather than the expected PXR pathway, providing a useful framework for studying brain drug metabolism.

• Protease Inhibitor Cocktail: Reliable Cell Assays

  2026-08-25

  Learn how Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO), SKU K1008, helps preserve protein endpoints linked to cell viability, proliferation, and cytotoxicity assays. This scenario-driven guide covers compatibility, dilution, interpretation, storage, and practical vendor selection.

• 2X HyperFusion High-Fidelity Master Mix for CRISPR PCR

  2026-08-25

  Build accurate cloning, genotyping, and CRISPR validation workflows with a ready-to-use mix designed for robust amplification and rapid cycling. Its proofreading chemistry generates blunt-ended products, helping researchers move from difficult templates to reliable sequencing and cloning with fewer optimization steps.

• Lymphodepletion Enhances Neoantigen T Cell Therapy

  2026-08-24

  The reference study identifies a KRAS.G12V-specific T cell receptor and shows that lymphodepleting chemotherapy can improve neoantigen-directed tumor killing by increasing immunoproteasome activity, HLA-I expression, and peptide presentation. Its findings position chemotherapy as an active modifier of tumor antigen visibility rather than merely a preparative treatment before adoptive cell therapy.

• Cy3 NHS ester (non-sulfonated) Protocol Guide

  2026-08-23

  Cy3 NHS ester (non-sulfonated) provides a covalent orange fluorescent label for primary amines in proteins, peptides, oligonucleotides, and DNA. It is appropriate for workflows that can tolerate DMSO or DMF, but should not be selected for aqueous-only labeling or samples highly sensitive to organic co-solvents without preliminary compatibility testing.

• Digoxin Research Workflows: Cardiac and Antiviral

  2026-08-22

  Build reproducible Digoxin assays that connect Na+/K+ ATPase inhibition with cardiac contractility modulation, arrhythmia treatment research, and cell-specific chikungunya experiments. This guide combines solution preparation, dose-response design, translational animal workflows, and troubleshooting for APExBIO SKU B7684.

• Fluorescein TSA Fluorescence System Kit Workflow

  2026-08-21

  The Fluorescein TSA Fluorescence System Kit converts weak HRP-linked signals into dense, localized fluorescein deposits for challenging IHC, ICC, and ISH experiments. This practical guide covers assay design, starting parameters, disease-focused applications, and troubleshooting for fluorescence detection of low-abundance biomolecules.

• BMS 309403: From FABP4 Binding to Foam Cells

  2026-08-21

  BMS 309403 is a potent, selective FABP4 inhibitor for dissecting lipid handling, macrophage inflammation, and foam-cell biology. This article translates recent SERCA2–calcineurin–FoxO1 findings into a causally informative experimental strategy rather than a simple inhibitor workflow.

• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-08-20

  The reference study developed chemically modified CDKN1A/p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. By restoring nuclear p21 expression, the approach constrained tumor-cell proliferation in vitro and suppressed orthotopic tumor growth in mice while limiting systemic distribution.

• Angiotensin 1/2 (5-7) Workflow Guide

  2026-08-20

  Build reproducible cardiovascular assays and hypothesis-driven receptor-binding studies with a defined H2N-Ile-His-Pro-OH peptide. This guide translates recent angiotensin–spike protein findings into practical preparation, controls, optimization, and troubleshooting steps.

• Lipidated Nanophotosensitizers Disable Tumor EVs

  2026-08-19

  The reference study developed a palmitic-acid-displayed nanophotosensitizer that both traces tumor extracellular vesicles and generates reactive oxygen species inside tumor cells and vesicles. In female mouse tumor models, this dual spatial action suppressed primary tumor growth while interrupting tumor extracellular vesicle communication linked to metastasis, offering a preclinical strategy that differs from nonspecific blockade of vesicle biogenesis.

444 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page